He H - Search Results

1

Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma.

Qiang W, Jin L, Luo T, Jia Y, Lu J, Liu J, He H, Qian Z, Mithraprabhu S, Liang Y, Gale RP, Tao X, Wu D, Du J. Qiang W, et al. Among authors: he h. Blood Cancer J. 2023 Sep 5;13(1):136. doi: 10.1038/s41408-023-00904-9. Blood Cancer J. 2023. PMID: 37669974 Free PMC article. No abstract available.

2

[Analysis of a pyruvate kinase deficiency consanguineous pedigree caused by Ile314Thr homozygous mutation].

Qu Y, He H, Du J, Hou J, Fu W. Qu Y, et al. Among authors: he h. Zhonghua Xue Ye Xue Za Zhi. 2014 Jul;35(7):601-4. doi: 10.3760/cma.j.issn.0253-2727.2014.07.007. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 25052601 Chinese.

3

The clinical characteristics and prognosis of IGH deletion in multiple myeloma.

He H, Fu W, Jiang H, Du J, Zhou L, Zhang C, Xi H, Li R, Hou J. He H, et al. Leuk Res. 2015 May;39(5):515-9. doi: 10.1016/j.leukres.2015.02.010. Epub 2015 Mar 18. Leuk Res. 2015. PMID: 25817540

4

[Response and prognosis of patients with multiple myeloma induced by PAD/TAD].

Zeng T, He H, Shi H, Xi H, Du J, Zhang C, Jiang H, Fu W, Zhou F, Hou J. Zeng T, et al. Among authors: he h. Zhonghua Yi Xue Za Zhi. 2015 Mar 17;95(10):731-5. Zhonghua Yi Xue Za Zhi. 2015. PMID: 26080842 Chinese.

5

[Efficacy and prognostic factors of induction therapy combined with autologous stem cell transplantation in 201 patients with multiple myeloma].

Jin L, Fu W, Xi H, Zhang C, Du J, He H, Jiang H, Zeng T, Fan J, Zhou L, Chang H, Hou J. Jin L, et al. Among authors: he h. Zhonghua Xue Ye Xue Za Zhi. 2016 Jan;37(1):14-9. doi: 10.3760/cma.j.issn.0253-2727.2016.01.003. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 26876247 Free PMC article. Chinese.

6

Successful treatment of newly diagnosed POEMS syndrome with reduced-dose bortezomib based regimen.

He H, Fu W, Du J, Jiang H, Hou J. He H, et al. Br J Haematol. 2018 Apr;181(1):126-128. doi: 10.1111/bjh.14497. Epub 2017 Feb 1. Br J Haematol. 2018. PMID: 28146276 Free article. No abstract available.

7

High Serum Lactate Dehydrogenase adds Prognostic Value to Cardiac Biomarker Staging System for Light Chain Amyloidosis.

He H, Liu J, Jiang H, Du J, Li L, Lu J, Fu W. He H, et al. J Cancer. 2019 Sep 7;10(23):5622-5627. doi: 10.7150/jca.30345. eCollection 2019. J Cancer. 2019. PMID: 31737098 Free PMC article.

8

Serum-free light chains combined with the Revised International Staging System could further distinguish the superior and inferior clinical outcome of multiple myeloma patients.

Du J, Lu J, Gao W, Liu J, He H, Li L, Li R, Zhou L, Jiang H, Chen W, Fu W, Hou J. Du J, et al. Among authors: he h. Ann Hematol. 2020 Aug;99(8):1779-1791. doi: 10.1007/s00277-020-04162-8. Epub 2020 Jun 27. Ann Hematol. 2020. PMID: 32594218

9

Single-cell RNA-seq reveals clonal diversity and prognostic genes of relapsed multiple myeloma.

He H, Li Z, Lu J, Qiang W, Jiang S, Xu Y, Fu W, Zhai X, Zhou L, Qian M, Du J. He H, et al. Clin Transl Med. 2022 Mar;12(3):e757. doi: 10.1002/ctm2.757. Clin Transl Med. 2022. PMID: 35297204 Free PMC article.

10

Development and validation of prognostic implications of chromosome abnormalities algorithm for newly diagnosed multiple myeloma.

Luo T, Qiang W, Lu J, He H, Liu J, Li L, Jiang H, Fu W, Du J. Luo T, et al. Among authors: he h. Blood Sci. 2020 Jul 29;3(3):78-86. doi: 10.1097/BS9.0000000000000077. eCollection 2021 Jul. Blood Sci. 2020. PMID: 35402836 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,387 results

Search Page

Filters